A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus
Oral Insulin Trial
ORMD-0801
Study Length: 12 Weeks
Target Age/Sex: 18 years and older with type 2 diabetes
Participants will receive at no cost: study product, study materials and study-specific procedures
Link: Clinicaltrials.gov